Objective To provide updated guidelines for pharmacologic management of juvenile
idiopathic arthritis (JIA), focusing on treatment of oligoarthritis, temporomandibular joint (TMJ) …

Objective To provide evidence‐based recommendations on the use of vaccinations in children
and adults with rheumatic and musculoskeletal diseases (RMDs). Methods This guideline …

Objective There is wide variation in therapeutic approaches to systemic juvenile idiopathic
arthritis (JIA) among North American rheumatologists. Understanding the comparative …

We hypothesized that neutrophil gelatinase-associated lipocalin (NGAL) is an early predictive
biomarker of disease activity in lupus nephritis. NGAL in serial plasma (PNGAL) and urine …

Objective To determine whether neutrophil gelatinase–associated lipocalin (NGAL) can
predict worsening of global and renal disease activity in childhood‐onset systemic lupus …

BACKGROUND Undifferentiated systemic autoinflammatory diseases (USAIDs) present
diagnostic and therapeutic challenges. Chronic interferon (IFN) signaling and cytokine …

Objective Systemic juvenile idiopathic arthritis (JIA) is characterized by fevers, rash, and
arthritis, for which interleukin‐1 (IL‐1) and IL‐6 inhibitors appear to be effective treatments. …

Objective To develop standardized treatment regimens for chronic nonbacterial osteomyelitis
(CNO), also known as chronic recurrent multifocal osteomyelitis (CRMO), to enable …

Objective To investigate the characteristics and risk factors of a novel parenchymal lung
disease (LD), increasingly detected in systemic juvenile idiopathic arthritis (sJIA). Methods In a …

Objective There is no standardized approach to the initial treatment of polyarticular juvenile
idiopathic arthritis (JIA) among pediatric rheumatologists. Understanding the comparative …